Dose prescription and treatment planning based on FMISO-PET hypoxia

Abstract Purpose. The study presents the implementation of a novel method for incorporating hypoxia information from PET-CT imaging into treatment planning and estimates the efficiency of various optimization approaches. Its focuses on the feasibility of optimizing treatment plans based on the non-linear conversion of PET hypoxia images into radiosensitivity maps from the uptake properties of the tracers used. Material and methods. PET hypoxia images of seven head-and-neck cancer patients were used to determine optimal dose distributions needed to counteract the radiation resistance associated with tumor hypoxia assuming various scenarios regarding the evolution of the hypoxic compartment during the treatment. A research planning system for advanced studies has been used to optimize IMRT plans based on hypoxia information from patient PET images. These resulting plans were compared in terms of target coverage for the same fulfilled constraints regarding the organs at risk. Results. The results of a planning study indicated the clinical feasibility of the proposed method for treatment planning based on PET hypoxia. Antihypoxic strategies would lead to small improvements in all the patients, but higher effects are expected for the fraction of patients with hypoxic tumors. For these, individualization of the treatment based on hypoxia PET imaging could lead to improved treatment outcome while creating the premises for limiting the irradiation of the surrounding normal tissues. Conclusions. The proposed approach offers the possibility of improved treatment results as it takes into consideration the heterogeneity and the dynamics of the hypoxic regions. It also provides early identification of the clinical cases that might benefit from dose escalation as well as the cases that could benefit from other counter-hypoxic measures.

[1]  D. Hristov,et al.  Adapting radiotherapy to hypoxic tumours , 2006, Physics in medicine and biology.

[2]  D. Olsen,et al.  Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study , 2007, Physics in medicine and biology.

[3]  A. Brahme,et al.  Biologically Optimized 3-Dimensional In Vivo Predictive Assay-based Radiation Therapy Using Positron Emission Tomography-Computerized Tomography Imaging , 2003, Acta oncologica.

[4]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[5]  S. Apisarnthanarax,et al.  Current Imaging Paradigms in Radiation Oncology , 2005, Radiation research.

[6]  A H Baydush,et al.  Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. , 2004, Medical physics.

[7]  A Brahme,et al.  Individualizing cancer treatment: biological optimization models in treatment planning and delivery. , 2001, International journal of radiation oncology, biology, physics.

[8]  A. J. Varghese,et al.  Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. , 1976, Cancer research.

[9]  R. Jeraj,et al.  Feasibility and sensitivity study of helical tomotherapy for dose painting plans , 2010, Acta oncologica.

[10]  Mikael Karlsson,et al.  Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. , 2003, Physics in medicine and biology.

[11]  TIKVAH ALPER,et al.  Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. , 1956, Nature.

[12]  Alexandru Daşu,et al.  Should single or distributed parameters be used to explain the steepness of tumour control probability curves? , 2003, Physics in medicine and biology.

[13]  C. Anderson,et al.  Radiation Oncology , 2001, Springer International Publishing.

[14]  T. Alper,et al.  Cellular radiobiology. , 1960, Annual review of nuclear science.

[15]  C. Ling,et al.  Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[16]  Alexandru Daşu,et al.  Treatment modelling: The influence of micro-environmental conditions , 2008, Acta oncologica.

[17]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Jens Overgaard,et al.  Resolution in PET hypoxia imaging: Voxel size matters , 2008, Acta oncologica.

[19]  G. Barendsen,et al.  Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. , 1982, International journal of radiation oncology, biology, physics.

[20]  H D Thames,et al.  Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  J. Chapman,et al.  The detection and measurement of hypoxic cells in solid tumors , 1984, Cancer.

[22]  Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .

[23]  A. Waites,et al.  Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? , 1998, Advances in enzyme regulation.

[24]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[25]  A Brahme,et al.  Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours. , 1995, Acta oncologica.

[26]  Tomio Inoue,et al.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Frederik Maes,et al.  Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG? , 2008, Acta oncologica.

[28]  Robert Jeraj,et al.  Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. , 2008, Physics in medicine and biology.

[29]  Peter Vaupel,et al.  Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.

[30]  J F Fowler,et al.  Letter: Fractionation schedules and a quadratic dose-effect relationship. , 1975, The British journal of radiology.

[31]  M Alber,et al.  On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.

[32]  J. Fowler The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[33]  Daniela Thorwarth,et al.  Implementation of hypoxia imaging into treatment planning and delivery. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Anders Brahme,et al.  Dose prescription and optimisation based on tumour hypoxia , 2009, Acta oncologica.

[35]  Sigrid Stroobants,et al.  Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.

[36]  A. Boyer,et al.  Inverse planning for functional image-guided intensity-modulated radiation therapy. , 2002, Physics in medicine and biology.

[37]  J. Denekamp,et al.  Inducible repair and the two forms of tumour hypoxia--time for a paradigm shift. , 1999, Acta oncologica.

[38]  M J Welch,et al.  Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  Michael Höckel,et al.  Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.

[40]  J. Bussink,et al.  Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. , 2002, International journal of radiation oncology, biology, physics.

[41]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[42]  Alexandru Daşu,et al.  Treatment planning optimisation based on imaging tumour proliferation and cell density , 2008, Acta oncologica.

[43]  D. Hedley,et al.  Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Anders Brahme,et al.  Therapy optimization based on non-linear uptake of PET tracers versus “linear dose painting” , 2009 .

[45]  Gig Mageras,et al.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[46]  K L Lindsley,et al.  Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.

[47]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  A. Scott,et al.  Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. , 2007, Seminars in nuclear medicine.

[49]  M. Schwaiger,et al.  Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[50]  A. Brahme,et al.  Optimal dose distribution for eradication of heterogeneous tumours. , 1987, Acta oncologica.

[51]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[52]  Jens Overgaard,et al.  Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.